Hormos Medical
7
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
43%
3 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
Role: collaborator
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Role: collaborator
A Clinical Study to Evaluate the Safety of Ospemifene
Role: collaborator
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Role: collaborator
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Role: collaborator
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Role: collaborator
A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
Role: collaborator
All 7 trials loaded